Yao Xu

7PUBLICATIONS
3CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tissue engineeringHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 13, 2026
Nicotinamide mononucleotide potentiates the anti-tumor efficacy of CAR-NK cell therapy targeting MSLN in ovarian cancer.

|Jan 28, 2026
Upregulation of the TCA Cycle and Oxidative Phosphorylation Enhances the Fitness of CD99 CAR-T Cells Under Dynamic Cultivation.

Jiaxuan Zhao, Youyong Wang, Yixuan Wang

|Feb 20, 2025
GABPα inhibits tumor progression and angiogenesis via a novel 18-bp indel within VEGF promoter in breast cancer.

Hui Guo, Yue Han, Qiaoyi Zhou

|May 07, 2024
Recent advances in CAR-T cell therapy for acute myeloid leukaemia.

Chi Gao, Xin Li, Yao Xu

|Nov 02, 2023
KRT19 is a Promising Prognostic Biomarker and Associates with Immune Infiltrates in Serous Ovarian Cystadenocarcinoma.

Zhe Sun, Ruijie Zhou, Jinjin Dai

|Aug 04, 2021
MRTF-A regulates myoblast commitment to differentiation by targeting PAX7 during muscle regeneration.

Ruhui Song, Shengnan Zhao, Yue Xu

Pageof 2

Frequent Collaborators

1 joint publications

Chi Gao

1 joint publications

Di Yao

1 joint publications

Hui Guo